Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-012752

Options or other derivatives

  • Chief Operating Officer acquired 25,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Keuer Thomas A · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-02-16 Grant or award : show line 1 in the form Stock Option (right to buy) +25,200 25,200 D
Loading xslF345X03/doc4.xml…